835 related articles for article (PubMed ID: 31164979)
1. Epidemiology and risk factors of methicillin-resistant
Huang L; Zhang R; Hu Y; Zhou H; Cao J; Lv H; Chen S; Ding S; Chen G
Antimicrob Resist Infect Control; 2019; 8():90. PubMed ID: 31164979
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
Wang Z; Cao B; Liu YM; Gu L; Wang C
Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
[TBL] [Abstract][Full Text] [Related]
3. Determining the clinical significance of co-colonization of vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in the intestinal tracts of patients in intensive care units: a case-control study.
Yoon YK; Lee MJ; Ju Y; Lee SE; Yang KS; Sohn JW; Kim MJ
Ann Clin Microbiol Antimicrob; 2019 Oct; 18(1):28. PubMed ID: 31601221
[TBL] [Abstract][Full Text] [Related]
4. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Smith JR; Yim J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
[TBL] [Abstract][Full Text] [Related]
5. Infant Colonization With Methicillin-Resistant Staphylococcus aureus or Vancomycin-Resistant Enterococci Preceding Neonatal Intensive Care Unit Discharge.
Clock SA; Jia H; Patel S; Ferng YH; Alba L; Whittier S; DeLaMora P; Tabibi S; Perlman J; Paul D; Zaoutis T; Larson E; Saiman L
J Pediatric Infect Dis Soc; 2017 Sep; 6(3):e144-e148. PubMed ID: 28339914
[TBL] [Abstract][Full Text] [Related]
6. Recovery of both vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus from culture of a single clinical specimen from colonized or infected patients.
Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CK; Kim CO; Yong D; Choi JY; Song YG; Lee K; Kim JM
Infect Control Hosp Epidemiol; 2009 Feb; 30(2):130-8. PubMed ID: 19128183
[TBL] [Abstract][Full Text] [Related]
7. Independent risk factors for the co-colonization of vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant Staphylococcus aureus isolation.
Hayakawa K; Marchaim D; Bathina P; Martin ET; Pogue JM; Sunkara B; Kamatam S; Ho K; Willis LB; Ajamoughli M; Patel D; Khan A; Lee KP; Suhrawardy U; Jagadeesh KK; Reddy SM; Levine M; Ahmed F; Omotola AM; Mustapha M; Moshos JA; Rybak MJ; Kaye KS
Eur J Clin Microbiol Infect Dis; 2013 Jun; 32(6):815-20. PubMed ID: 23354672
[TBL] [Abstract][Full Text] [Related]
8. A hidden reservoir of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in patients newly admitted to an acute rehabilitation hospital.
Rabinowitz RP; Kufera JA; Makley MJ
PM R; 2012 Jan; 4(1):18-22. PubMed ID: 22269450
[TBL] [Abstract][Full Text] [Related]
9. Reduction in rates of methicillin-resistant Staphylococcus aureus infection after introduction of quarterly linezolid-vancomycin cycling in a surgical intensive care unit.
Smith RL; Evans HL; Chong TW; McElearney ST; Hedrick TL; Swenson BR; Scheld WM; Pruett TL; Sawyer RG
Surg Infect (Larchmt); 2008 Aug; 9(4):423-31. PubMed ID: 18759679
[TBL] [Abstract][Full Text] [Related]
10. Detection of vancomycin resistance in enterococcus species isolated from clinical samples and feces of colonized patients by phenotypic and genotypic methods.
Biswas PP; Dey S; Adhikari L; Sen A
Indian J Pathol Microbiol; 2016; 59(2):188-93. PubMed ID: 27166038
[TBL] [Abstract][Full Text] [Related]
11. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
[TBL] [Abstract][Full Text] [Related]
12. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents.
Hsueh PR; Chen WH; Teng LJ; Luh KT
Int J Antimicrob Agents; 2005 Jul; 26(1):43-9. PubMed ID: 15975769
[TBL] [Abstract][Full Text] [Related]
13. [In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains].
Efe S; Sinirtaş M; Ozakin C
Mikrobiyol Bul; 2009 Oct; 43(4):639-43. PubMed ID: 20084917
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.
Chen KH; Huang YT; Liao CH; Sheng WH; Hsueh PR
Antimicrob Agents Chemother; 2015 Oct; 59(10):6262-5. PubMed ID: 26248355
[TBL] [Abstract][Full Text] [Related]
15. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and other Gram-positives in healthcare.
Calfee DP
Curr Opin Infect Dis; 2012 Aug; 25(4):385-94. PubMed ID: 22614523
[TBL] [Abstract][Full Text] [Related]
16. Bacterial susceptibility in bloodstream infections: Results from China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2015-2016.
Zhang F; Li Y; Lv Y; Zheng B; Xue F
J Glob Antimicrob Resist; 2019 Jun; 17():276-282. PubMed ID: 30611932
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization in liver transplant recipients.
Kim YJ; Kim SI; Choi JY; Yoon SK; You YK; Kim DG
Korean J Intern Med; 2015 Sep; 30(5):694-704. PubMed ID: 26354064
[TBL] [Abstract][Full Text] [Related]
18. Methicillin- and Vancomycin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci Isolated from Hospital Foods: Prevalence and Antimicrobial Resistance Patterns.
Afshari A; Taheri S; Hashemi M; Norouzy A; Nematy M; Mohamadi S
Curr Microbiol; 2022 Sep; 79(11):326. PubMed ID: 36125553
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of colonization and infection with methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus and of Clostridium difficile infection in Canadian hospitals.
Simor AE; Williams V; McGeer A; Raboud J; Larios O; Weiss K; Hirji Z; Laing F; Moore C; Gravel D;
Infect Control Hosp Epidemiol; 2013 Jul; 34(7):687-93. PubMed ID: 23739072
[TBL] [Abstract][Full Text] [Related]
20. [In vitro activity of daptomycin against VRE and MRSA strains].
Aktaş G; Derbentli S
Mikrobiyol Bul; 2014 Jan; 48(1):123-8. PubMed ID: 24506722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
